SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

Similar documents
Clinical Study Small Bowel Tumors: Clinical Presentation, Prognosis, and Outcomein33PatientsinaTertiaryCareCenter

CT PET SCANNING for GIT Malignancies A clinician s perspective

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Navigators Lead the Way

COLORECTAL CARCINOMA

Together, putting patients first

11/21/13 CEA: 1.7 WNL

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

Evaluation of Suspected Pancreatic Cancer

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

Clinical presentations of small bowel tumor

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY

Surgery for Gastric and Oesophageal Cancer

GASTROINTESTINAL MALIGNANCIES

Lek. Agnieszka Słowik Oddział Kliniczny Onkologii Collegium Medicum UJ

Afternoon Session Cases

Surveillance of Individuals At High Risk For Developing Pancreatic Cancer

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1

PANCREAS DUCTAL ADENOCARCINOMA PDAC

Imaging in gastric cancer

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Case Report A Rare Case of Mucinous Adenocarcinoma of the Colon Presenting as Ileoileal Intussusception in an Adult

Hilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht

L impatto dell imaging sulla definizione della strategia terapeutica

Principles of diagnosis, work-up and therapy The Gastroenterologist s role

Surgical Management of Pancreatic Cancer

Esophageal cancer: Biology, natural history, staging and therapeutic options

Colonic Polyp. Najmeh Aletaha. MD

Multiple Primary Quiz

Imaging of Neuroendocrine Metastases

INVESTIGATIONS OF GASTROINTESTINAL DISEAS

Index. Note: Page numbers of article titles are in boldface type.

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Case Scenario 1. Discharge Summary

Biliary tree dilation - and now what?

Barrett s Esophagus: Old Dog, New Tricks

PANCREATIC CANCER GUIDELINES

This page explains some of the medical words that you may hear when you are finding out about pancreatic cancer and how it is treated.

By: Tania Cortas, MD Arizona Oncology 03/10/2015

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas

Peutz Jegher's Syndrome (Gastro-intestinal Polyposis) and Its Complications

Surgical Therapy of GEP-NET: An Overview

NET und NEC. Endoscopic and oncologic therapy

LIST OF ABBREVIATIONS

When to Refer for OGD and the Work Up of Upper GI Malignancies

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

Burkitt s Lymphoma of the Abdomen: The Northern California Kaiser Permanente Experience

Capsule Endoscopy: Present & Future

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Disclosure of Relevant Financial Relationships

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Intraoperative staging of GIT cancer using Intraoperative Ultrasound

Surgical. Gastroenterology. Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies

Familial and Hereditary Colon Cancer

Adult Intussusception

Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy

Small Intestine Cancer Early Detection, Diagnosis, and Staging

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

CRITICAL ANALYSIS OF NEN GUIDELINES. G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

Pancreatic Cancer. What is pancreatic cancer?

ADJUVANT CHEMOTHERAPY...

The Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon

The incidence of pancreatic cancer is rising in India and is higher in the urban male population in the western and northern parts of India.

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital

Pancreatic Cancer. BIOLOGY: Not well defined (genetic and enviromental factors) CLINICAL PRESENTATION: Abd pain, jaundice, weight loss.

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Bowel obstruction and tumors

Evidence tabel stadiering

Interactive Staging Bee

Endoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy

Management of an Appendiceal Mass - Approach to acute presentation of appendiceal neoplasms

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Guidelines for Laparoscopic Resection of Curable Colon and Rectal Cancer

Citation for published version (APA): Bartels, S. A. L. (2013). Laparoscopic colorectal surgery: beyond the short-term effects

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Стенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts»

COLORECTAL CANCER CASES

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons

Colorectal cancer Chapelle, J Clin Oncol, 2010

Radiation Oncology MOC Study Guide

CASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES

Follow this and additional works at: Part of the Neoplasms Commons

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

Transcription:

SMALL BOWEL ADENOCARCINOMA Dr. C. Jeske

Case presentation 54 year old female. Presents with OJ and weight loss. Abdominal examination only reveals a palpable gallbladder.

ERCP reveals a circumferential tumour at D1/2 involving ampulla Stent placed The tumour was biopsied and confirmed moderately differentiated adenocarcinoma.

Laparoscopy was performed to exclude peritoneal metastases. Pancreaticoduodenectomy was performed. The tumour was confined to the duodenum and there was no obvious spread. Awaiting final histology

Incidence Small bowel makes up 75% of length and 90% of mucosal surface. Despite this = rare cancer. US data = 22.7/million(2004) All tumours = 0.5-1.5/100000 in males and 0.2-1.0/100000 in females Small bowel adenocarcinoma(sba) accounts for 40%

Site and frequency: Duodenum = 55-82% Jejunum = 11-25% Ileum = 7-17% Median age = sixth decade

Etiopathogenesis Environmental factors: Alcohol and smoking Increased risk: highest consumers of sugar, refined carbohydrates, red meat and smoked food. Decreased risk: coffee, fish, fruit and vegetables. Lower incidence of SBA as opposed to colorectal malignancies: Shorter contact time Low concentration of aerophilin Gram + bacteria in SB Decreased density of microbiota Epithelial cells of SB wide range of microsomal enzymes

Carcinogenesis Same range of genes tested for colorectal. Suggests shared carcinogenesis pathway. However; APC mutation less often observed, MMR phenotype more frequent in SBA. Progress limited by small numbers and selection bias.

Genetic predisposition FAP Lynch syndrome Peutz-Jeghers syndrome

Other predisposing conditions Crohn s disease Coeliac disease

Clinical presentation Abdominal pain (43%) Nausea and vomiting (16%) Fatigue and anaemia (15%) Upper or lower GIT bleeding (7%) Jaundice (6%) Failure to obtain diagnostic test or misinterpretation = delays of 8-12 months.

Diagnosis Single center study 217 pts, diagnoses were obtained by: Upper GI endoscopy (28%) Surgery (26%) Small bowel barium transit (22%) CT scan (18%) U/sound (3%) Physical examination (3%) Diagnosis mainly obtained at advanced stages: 35% synchronous metastases 39% lymph-node invasion Dabaja et al, Cancer 2004.

Sensitivity of SB barium transit and plain contrasted abdominal CT scan: 50% and 47%. Context of obscure bleeding after upper and lower endoscopy SB investigation systematically done. Range of options. CT enteroclysis: sens = 85-95% and spec = 90-96%. Capsule endoscopy: sens = 88-95% spec = 75-95%.

Investigations after diagnosis Thoraco-abdomino-pelvic CT to assess distant metastases. Upper and lower endoscopy to look for synchronous lesions, esp. in pts with genetic predisposition. Baseline CEA and Ca 19-9. In pts with predisposing genetic disease and Crohn s full small bowel exploration. Suspected Lynch syndrome according to protocol.

Prognosis Survival according to cancer stage. AJCC Stage Incidence (%) 5-year OS (%) 1 4-12 50-60 2 14-30 39-55 3 19-27 10-40 4 32-46 3-5 Aparicio et al, Dig and Liv Disease 2014.

Lymph-node invasion = main prognostic factor 5-year disease free-survival = 57% 2/less nodes vs. 37% 3/> nodes. Significant predictors of poor OS on multivariate analysis: Advanced age Advanced stage Ileal location Recovery of <10 lymph nodes Number of positive nodes

Recurrence rate shown to be as high as 16% in one study. Prolonged follow-up indicated. Overman et al, Acta Oncologica 2010.

Treatment Surgery remains the only potentially curative treatment. Locally advanced cancer found to be irresectable at surgery = 5%.

Surgery Indicated for localised cancer. Complete resection (R0) of primary tumour + locoregional lymph node resection is mandatory. Context of posterior invasion neoadjuvant treatment. Primary tumour resection in context of unresectable metastases is not recommended except if lesion complicates. Insufficient data on metastatectomy.

Duodenal tumours: Pancreaticoduodenectomy with lymph node resection. Jejunal and ileal tumours: R0 resection with lymph node resection and jejunojejunal or ileo-ileal anastomosis. Distal ileum: Right hemicolectomy with ligation of ileocolic artery for adequate lymph node resection.

Conclusion Rare cancers. Must maintain high index of suspicion. Often diagnosed at advanced stages. New diagnostic modalities should be used more readily. Better prognosis than gastric or pancreatic cancers but worse prognosis than colorectal carcinoma.